###begin article-title 0
###xml 84 90 84 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2</italic>
Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 389 396 389 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
The glutamatergic dysfunction hypothesis of schizophrenia suggests that genes involved in glutametergic transmission are candidates for schizophrenic susceptibility genes. We have been performing systematic association studies of schizophrenia with the glutamate receptor and transporter genes. In this study we report an association study of the excitatory amino acid transporter 2 gene, SLC1A2 with schizophrenia.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
We genotyped 100 Japanese schizophrenics and 100 controls recruited from the Kyushu area for 11 single nucleotide polymorphism (SNP) markers distributed in the SLC1A2 region using the direct sequencing and pyrosequencing methods, and examined allele, genotype and haplotype association with schizophrenia.The positive finding observed in the Kyushu samples was re-examined using 100 Japanese schizophrenics and 100 controls recruited from the Aichi area.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 104 106 104 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 357 359 357 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 369 371 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 373 375 373 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
We found significant differences in genotype and allele frequencies of SNP2 between cases and controls (P = 0.013 and 0.008, respectively). After Bonferroni corrections, the two significant differences disappeared. We tested haplotype associations for all possible combinations of SNP pairs. SNP2 showed significant haplotype associations with the disease (P = 9.4 x 10-5, P = 0.0052 with Bonferroni correction, at the lowest) in 8 combinations. Moreover, the significant haplotype association of SNP2-SNP7 was replicated in the cumulative analysis of our two sample sets.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
We concluded that at least one susceptibility locus for schizophrenia is probably located within or nearby SLC1A2 in the Japanese population.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G72 </italic>
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NRG1 </italic>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Schizophrenia is a severe mental disorder characterized by hallucinations, delusions, disorganized thoughts, and various cognitive impairments. The life-time prevalence is about 1%, and genetic factors were known to play a critical role in its pathogenesis [1]. Based on the fact that phencyclidine (PCP) induces schizophreniform psychosis, a glutamatergic dysfunction hypothesis has been proposed for the pathogenesis of schizophrenia [2-4]. This hypothesis has been supported by recent multiple reports of association of schizophrenia with glutamate receptor genes and with the genes related to glutamatergic transmission, such as G72 and NRG1 [5-10].
###end p 11
###begin p 12
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
In addition, other synaptic elements related to glutamate, such as excitatory amino acid transporters (EAATs), also potentially affect glutamatergic neurotransmission. EAATs maintain extracellular glutamate concentrations within physiological levels by reuptaking the synaptically released glutamate. A deficient uptake has been implicated in the pathogenesis of ischemic brain damage [11] and may be involved in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) [12]. Recently significant increases of mRNA expression of EAAT1 and EAAT2 have been reported in the thalamus of schizophrenics, suggesting the possibility that an excessive glutamate uptake is involved in schizophrenia [13]. On the other hand, a significant decrease of EAAT2 mRNA expression was observed in the parahippocampal gyrus of schizophrenics [14]. Therefore the EAAT genes are reasonable candidates for schizophrenia, as well as glutamate receptor genes.
###end p 12
###begin p 13
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2</italic>
###xml 359 366 359 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 529 536 529 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
The EAATs family consists of five members (EAAT1-EAAT5). Their cellular localizations are different: EAAT1 and EAAT2 are astroglial, whereas EAAT3 EAAT4 and EAAT5 are neuronal [25]. Since EAAT2 accounts for approximately 90% of glutamate reuptake in the rodent forebrain [16,17], we focused on the EAAT2 gene (SLC1A2) in association studies of schizophrenia. SLC1A2 has been mapped to 11p13-p12 [18] and consists of 11 exons spanning over 165 kb. In this study we tested associations of schizophrenia with 11 SNPs distributed in SLC1A2 with an average interval of 15.9 kb. To enhance the detection power of the study, we also examined the haplotype associations of the SNPs with the disease.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects
###end title 15
###begin p 16
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 604 612 <span type="species:ncbi:9606">patients</span>
###xml 771 779 <span type="species:ncbi:9606">patients</span>
Blood samples were obtained from unrelated Japanese individuals who had provided written informed consent. We used two Japanese sample sets in this study. In the first one, Kyushu samples, 100 schizophrenia patients (mean age 49.5; 44.0% female) were recruited from hospital in the Fukuoka and Oita areas and 100 healthy unrelated controls (mean age 51.2; 44.0% female) were recruited from the Fukuoka area. In the initial SNP selection process, we used another 16 Japanese samples which are recruited in the Fukuoka area and informed in the same way. In the second one, Aichi samples, 100 schizophrenia patients (mean age 34.4; 44% female) and 100 healthy unrelated controls (mean age 39.9; 45% female) were collected in the Aichi area about 600 km east of Fukuoka. All patients fulfilled the DSM-IV criteria for schizophrenia [19]. All of the case and control samples are ethnically Japanese. DNA samples were purified from whole peripheral blood by the method previously described [20]. This study was approved by the Ethics Committee of Kyushu University, Faculty of Medicine and the Fujita Health University Ethics Committee.
###end p 16
###begin title 17
SNP selection in the SLC1A2 region
###end title 17
###begin p 18
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2</italic>
###xml 756 757 756 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1012 1013 1012 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
We retrieved the primary SNP information from the dbSNP database . Assuming the same size of the half length of linkage disequilibrium (LD) (60 kb) as reported in Caucasians [21], we initially intended to select common SNPs every 50 kb in SLC1A2. We tested 22 candidate SNPs including all of the exonic SNPs, in the 16 healthy Japanese samples by the direct sequencing method. Out of the 22 SNPs we selected the following 7 common SNPs with minor allele frequencies over 10% for further analyses: SNP1, rs1923295; SNP3, rs4534557; SNP6, rs1885343; SNP8, rs752949; SNP9, rs1042113; SNP10, rs3838796; SNP11, rs1570216. We also identified a novel SNP, SNP7, in intron 1 (conting location: 34105026). After the LD analyses described below, we noticed LD gaps (D' < 0.3) of the initial SNP set and examined additional 20 candidate SNPs. Out of the 20 SNPs, we selected the following 3 SNPs to fill the LD gaps: SNP2, rs4755404; SNP4, rs4756224; SNP5, rs1923298. The locations of the total 11 SNPs are shown in Figure 1.
###end p 18
###begin p 19
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genomic organization of <italic>SLC1A2 </italic>and locations of the SNPs. </bold>
Genomic organization of SLC1A2 and locations of the SNPs. Exons are shown as vertical bars with exon numbers. Eleven SNPs are indicated by circles. Distances between the SNPs are indicated above with kb.
###end p 19
###begin title 20
Genotyping
###end title 20
###begin p 21
###xml 98 115 98 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">additional file 1</xref>
###xml 265 266 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 302 306 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 685 702 660 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">additional file 1</xref>
###xml 1027 1028 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1093 1095 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
Eleven SNPs were amplified as 11 individual fragments by PCR using the primers shown in Table 1 - additional file 1. The reaction mixture for PCR was prepared in a total volume 10 mul with 5 ng of genomic DNA, 10 pmol of each primer (4 pmol of SNP3), 2.5 mM of MgCl2, 0.2 mM of each dNTP and 0.25 U of Taq DNA polymerase. An initial denaturing step of 1 min at 94degreesC was followed by 30, 35 or 40 cycles of 94degreesC for 30 sec, appropriate annealing temperature for 30 sec and 72degreesC for 30 sec. A final extension step was carried out at 72degreesC for 7 min. The nucleotide sequences of each primer, PCR conditions and genotyping methods for each SNP are shown in Table 1 - additional file 1. We genotyped SNP3 by pyrosequencing analysis on a PSQtrade mark96MA Pyrosequencer according to the manufacturer's specifications with a biotinylated reverse primer (5'-CGCCTACTCCTGGTGACTTC-3'), and the sequencing primer (5'-CGCCCCCATGTGT-3'). The other 10 SNPs were genotyped by direct sequencing, as previously described [7]. The raw data of direct sequencing were compiled on PolyPhred [22].
###end p 21
###begin title 22
Statistical analyses
###end title 22
###begin p 23
###xml 108 109 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 240 241 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 361 362 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 368 369 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 369 371 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 446 448 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 542 544 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
To control genotyping errors, Hardy-Weinberg equilibrium (HWE) was checked in the control samples by the chi2-test (d.f. = 1). We evaluated the statistical differences in genotype and allele frequencies between cases and controls by the chi2-test (d.f. = 2) and the Fisher's exact probability test (d.f. = 1), respectively. The magnitude of LD was evaluated in D' and r2 using the haplotype frequencies estimated by the EH program, version 1.14 [23]. Statistical analysis of the haplotype association was carried out as previously described [24]. The significance level for all statistical tests was 0.05.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
Genotyping and SNP association analysis
###end title 25
###begin p 26
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 142 159 142 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">additional file 2</xref>
###xml 384 386 384 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 498 500 498 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 539 540 539 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 540 545 540 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink">corr </sub>
###xml 554 555 554 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 555 560 555 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">corr </sub>
We selected 11 SNPs at average interval of 15.9 kb to cover the entire SLC1A2 region with LD as described in Materials and Methods. Table 2 - additional file 2. shows the results of genotype and allele frequencies of SNPs in case and control samples. No significant deviation from HWE in control samples was observed (data not shown). SNP2 showed significant differences in genotype (P = 0.013) and allele (P = 0.008) frequencies between cases and controls. After Bonferroni corrections, these two P values became non-significance levels (Pcorr = 0.143, Pcorr = 0.088, respectively).
###end p 26
###begin title 27
Pairwise linkage disequilibrium and haplotype association analyses
###end title 27
###begin p 28
###xml 97 98 97 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 105 107 105 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 118 135 118 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">additional file 3</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 419 420 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 468 469 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 566 567 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 755 756 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
We compared the magnitude of LD for all possible pairs of the 11 SNPs in controls by calculating D' and r2 (Table 3 - additional file 3. , upper diagonal), because LD around common alleles can be measured with a modest sample size of 40-50 individuals to a precision equal to 10-20% of the asymptotic limit [19]. We observed relatively strong LD (D' > 0.8) in the seven combinations: SNP4-SNP5 (D' = 0.800), SNP7-SNP8 (D' = 0.877), SNP8-SNP9 (D' = 0.925), SNP4-SNP11 (D' = 0.838), SNP5-SNP11(D' = 0.999), SNP7-SNP11 (D' = 0.816), SNP9-SNP11 (D' = 0.819). Modest LD (D' > 0.4) was observed in the combinations of adjacent SNPs except for SNP5-SNP6 (D' = 0.286) in the control samples. However, modest LD was detected in cases in the SNP5-SNP6 combination (D' = 0.497).
###end p 28
###begin p 29
###xml 83 100 83 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">additional file 3</xref>
###xml 211 213 211 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 235 237 235 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 259 261 259 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 283 285 283 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 307 309 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 319 321 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 335 337 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 360 362 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 388 390 388 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 498 503 498 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">corr </sub>
We constructed pairwise haplotypes for all of the 55 possible SNP pairs (Table 3 - additional file 3. , lower diagonal). We observed significant associations with schizophrenia in eight combinations: SNP2-SNP3 (P = 0.0021), SNP2-SNP4 (P = 0.0274), SNP2-SNP5 (P = 0.0054), SNP2-SNP6 (P = 0.0178), SNP2-SNP7 (P = 9.4 x 10-5), SNP2-SNP9 (P = 0.0354), SNP2-SNP10 (P = 0.0089) and SNP2-SNP11 (P = 0.0216). The combination of SNP2-SNP7 was the only one remained significant after Bonferroni correction (Pcorr = 0.0052).
###end p 29
###begin title 30
Cumulative analysis using the second sample set
###end title 30
###begin p 31
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 355 357 355 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 366 368 366 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 421 423 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 582 584 582 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 594 596 594 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
###xml 609 626 609 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">additional file 4</xref>
In this study, we detected significant associations of one haplotype in the SLC1A2 region with schizophrenia in the Kyushu samples. To confirm the positive finding, we investigated the second Japanese sample set recruited from the Aichi area. Although significant association of the disease was observed with neither genotype, allele frequencies of SNP2 (P = 0.195, P = 0.178, respectively), nor haplotypes of SNP2-SNP7 (P = 0.084) in the second sample set, the significant haplotype association of SNP2-SNP7 was replicated in the cumulative analysis including the two sample sets (P = 5.0 x 10-4) (Table 4 - additional file 4. ).
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 446 453 446 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
SLC1A2 is located on the chromosomal region of 11p13-p12, to which no evidence has been reported for linkage of schizophrenia, [25,26]. However, there is still a possibility that SLC1A2 is a candidate for schizophrenia susceptibility genes, because linkage studies could only detect genes with the large genotype relative risk [27]. We carried out the genotyping of 100 cases and 100 controls for 11 SNPs, which were selected to cover the entire SLC1A2 region with LD. Since minor allele frequencies of each SNP we tested ranges from 0.220 to 0.485, the expected detection power of our case-control study is from 0.89 to 0.94 for the susceptibility gene assuming 2 for genotype relative risk [28].
###end p 33
###begin p 34
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 265 282 265 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">additional file 3</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
Modest LD (D' = 0.925 ~ 0.409) was observed in the combinations of neighboring SNPs except for SNP5-SNP6 (D' = 0.286) in the control samples, suggesting that there may be a recombination hot spot present in the small region (7.8 kb) between the two SNPs (Table 3 - additional file 3. ). We plotted the magnitude of LD with the physical distance for each pair of the SNPs, and estimated the average half-length of LD to be 31.8 kb by assuming a linear regression (Fig. 2). This is approximately half of the previously estimated size 60 kb in a United States population of north-European descent [21].
###end p 34
###begin p 35
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A plot of pairwise linkage disequilibrium (LD) vs. physical distance between the SNPs in the <italic>SLC1A2 </italic>region. </bold>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 151 153 151 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 256 263 256 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
A plot of pairwise linkage disequilibrium (LD) vs. physical distance between the SNPs in the SLC1A2 region. D' were plotted with filled diamonds, and r2 with open diamonds. From the regression line, the half-length of LD was estimated to be 31.8 kb in the SLC1A2 region.
###end p 35
###begin p 36
###xml 57 59 57 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 80 82 80 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 148 165 148 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">additional file 2</xref>
###xml 374 381 374 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 633 640 633 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 412 419 <span type="species:ncbi:9606">patient</span>
Significant associations of schizophrenia with genotype (P = 0.013) and allele (P = 0.008) frequencies of SNP2 (rs4755404) were detected (Table 2 - additional file 2. ). However, none of these "single-marker" associations survived after Bonferroni corrections. An A-G transition in codon 206, causing a substitution of serine for asparagine, was identified in the exon 5 of SLC1A2 in a heterozygous sporadic ALS patient [29]. Since located in a putative glycosylation site, the nonsynonymous SNP is potentially involved in the pathophysiology of schizophrenia through affecting the glycosylation status and the transport activity of SLC1A2 [30]. No occurrence of the G allele of the SNP in 124 Italian schizophrenic and 50 control subjects has been reported [30]. We found also only A allele of the SNP in the 100 controls and 100 cases of the Kyushu samples (data not shown).
###end p 36
###begin p 37
###xml 109 111 109 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 202 204 202 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 214 216 214 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-5</sup>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 219 224 219 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">corr </sub>
###xml 539 541 539 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 551 553 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-4</sup>
In pairwise haplotype association analyses, SNP2 consistently showed significant haplotype associations. The P value of the combination SNP2-SNP7 was still significant even after Bonferroni correction (P = 9.4 x 10-5, Pcorr = 0.0052). In our second sample set, the Aichi sample, no significant association of SNP2 was observed in any of the analyses of genotypes, alleles and haplotypes. Cumulative analyses of the two sample sets, however, provide the replication of the significant haplotype association of SNP2-SNP7 with schizophrenia (P = 5.0 x 10-4). The frequency of the G-C haplotype in schizophrenics (26.6%) was notably higher than in controls (5.6%), suggesting that the G-C haplotype may be a risk haplotype for schizophrenia. We observed that the G-C haplotype frequency of schizophrenics (20.0%) was only slightly higher than controls (14.2%) in the Aichi sample, suggesting a less contribution of this locus on schizophrenia pathogenesis in the Aichi sample, although no apparent difference in clinical subtypes between both sample sets studied in this paper. The positive association reported here needs to be validated in larger sample sets, and it would also be worthwhile to search for functional SNPs in the region spanning SNP2-SNP7.
###end p 37
###begin title 38
Conclusion
###end title 38
###begin p 39
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
We concluded that at least one susceptibility locus for schizophrenia is probably located within or nearby SLC1A2 in the Japanese population.
###end p 39
###begin title 40
Competing interests
###end title 40
###begin p 41
None declared.
###end p 41
###begin title 42
List of abbreviations used
###end title 42
###begin p 43
SNP; single nucleotide polymorphism
###end p 43
###begin p 44
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
DSM-IV; dianostic and statistical manual of mental disorders, 4th edn
###end p 44
###begin p 45
PCR; polymerase chain reaction
###end p 45
###begin p 46
HWE; Hardy-Weinberg equilibrium
###end p 46
###begin p 47
LD; linkage disequilibrium
###end p 47
###begin p 48
EAAT; excitatory amino acid transporter
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
XD carried out genotyping, statistical analyses and drafted the manuscript: HS participated in design of this study and statistical analyses: HN, NT, NI and NO participated in collecting specimens and clinical data: YF conceived of the study and participated in its design and coordination.
###end p 50
###begin title 51
Pre-publication history
###end title 51
###begin p 52
The pre-publication history for this paper can be accessed here:
###end p 52
###begin p 53

###end p 53
###begin title 54
Supplementary Material
###end title 54
###begin title 55
Additional file 1
###end title 55
###begin p 56
 PCR primers for genotyping of SNPs in SLC1A2.
###end p 56
###begin p 57
Click here for file
###end p 57
###begin title 58
Additional file 2
###end title 58
###begin p 59
Genotype and allele frequencies of SNPs in SLC1A2 in Kyushu samples.
###end p 59
###begin p 60
Click here for file
###end p 60
###begin title 61
Additional file 3
###end title 61
###begin p 62
Pairwise linkage disequilibrium and haplotype association in SLC1A2.
###end p 62
###begin p 63
Click here for file
###end p 63
###begin title 64
Additional file 4
###end title 64
###begin p 65
Association analysis of the SNP2-SNP7 haplotype using two sample sets.
###end p 65
###begin p 66
Click here for file
###end p 66
###begin title 67
Acknowledgements
###end title 67
###begin p 68
We are grateful to all the medical staff involved in collecting specimens. This work was supported in part by a Grant-in Aid for Scientific Research on Priority Areas "Medical Genome Science" and other grants from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare of Japan.
###end p 68
###begin article-title 69
Genetic basis of schizophrenia
###end article-title 69
###begin article-title 70
Study of a new schizophrenomimetic drug, sernyl
###end article-title 70
###begin article-title 71
Recent advances in the phencyclidine model of schizophrenia
###end article-title 71
###begin article-title 72
###xml 0 4 <span type="species:ncbi:10090|species:ncbi:10095">Mice</span>
Mice with reduced NMDA receptor expression display behaviors related to schizophrenia
###end article-title 72
###begin article-title 73
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRIK3</italic>
Association between the ionotropic glutamate receptor kainate 3 (GRIK3) ser310ala polymorphism and schizophrenia
###end article-title 73
###begin article-title 74
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRIN1 </italic>
Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia
###end article-title 74
###begin article-title 75
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRIA4</italic>
Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia
###end article-title 75
###begin article-title 76
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRM3</italic>
Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia
###end article-title 76
###begin article-title 77
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GRM8</italic>
Positive associations of polymorphisms in the metabotropic glutamate receptor type 8 gene (GRM8) with schizophrenia
###end article-title 77
###begin article-title 78
The molecular genetics of schizophrenia: new findings promise new insights
###end article-title 78
###begin article-title 79
###xml 46 49 <span type="species:ncbi:10116">rat</span>
Characterization of D-aspartic acid uptake by rat hippocampal slices and effect of ischemic conditions
###end article-title 79
###begin article-title 80
Knockout of glutamate transporters reveals a major role for astroglial transport in excitoxicity and clearance of a glutamate
###end article-title 80
###begin article-title 81
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia
###end article-title 81
###begin article-title 82
Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus
###end article-title 82
###begin article-title 83
Cellular distribution and kinetic properties of high-affinity glutamate transporters
###end article-title 83
###begin article-title 84
Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
###end article-title 84
###begin article-title 85
###xml 45 49 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1
###end article-title 85
###begin article-title 86
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC1A2 </italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Assignment of the gene SLC1A2 coding for the human glutamate transporter EAAT2 to human chromosome 11 bands p13-p12
###end article-title 86
###begin article-title 87
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
###end article-title 87
###begin article-title 88
###xml 29 34 <span type="species:ncbi:9606">human</span>
Linkage disquilibrium in the human genome
###end article-title 88
###begin article-title 89
Polyphred: substitutions using fluorescence-based resequencing
###end article-title 89
###begin article-title 90
Testing linkage disequilibrium between a disease gene and marker loci
###end article-title 90
###begin article-title 91
Molecular genetics of schizophrenia: a critical review
###end article-title 91
###begin article-title 92
Initial genome-wide scan for linkage with schizophrenia in the Japanese Schizophrenia Sib-Pair Linkage Group (JSSLG) families
###end article-title 92
###begin article-title 93
Searching for genetic determinants in the new millennium
###end article-title 93
###begin article-title 94
Comparison of statistical power between 2 x 2 allele frequency and positivity tables in case-control studies of complex disease genes
###end article-title 94
###begin article-title 95
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis
###end article-title 95
###begin article-title 96
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects
###end article-title 96

